Claim: Christian Karsten Hansen held positions as senior scientist, co-founded Profound Pharma in Denmark and was involved in investment.
Evidence: Hansen held positions as senior scientist and director of intellectual property management at Novo Nordisk 1992–1999, and was a member of Enzyme Research Management. He co-founded one of the early Danish biotechnology companies, Profound Pharma, in 1999, with Jan Møller Mikkelsen, and remained co-CEO thereof until its acquisition by Maxygen in 2000. In 2001, he co-founded the investment firm Nordic Biotech Advisors, subsequently renamed NB Capital. Also in 2001, he founded C Hansen Invest. Created in Denmark in 1999 by Christian Karsten Hansen and Jan Møller Mikkelsen, formerly of Novo Nordisk, the company was funded by venture capital and a loan from Vækstfonden.